A Randomized, Parallel-Arm, Active Control, Multicenter Study Assessing the Safety and Efficacy of Dextenza for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract

Grants and Contracts Details

StatusActive
Effective start/end date12/15/201/24/25

Funding

  • Ocular Therapeutix Incorporated: $27,264.00